Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 5/2015

01-11-2015 | General Gynecology

Early versus late misoprostol administration after mifepristone for medical abortion

Authors: Rene Tendler, Jacob Bornstein, Mohamad Kais, Irina Masri, Marwan Odeh

Published in: Archives of Gynecology and Obstetrics | Issue 5/2015

Login to get access

Abstract

Purpose

To evaluate the successful medical termination of pregnancy comparing two regimens: misoprostol 2 or 48 h after mifepristone administration.

Design

Prospective randomized study.

Setting

Department of Obstetrics and Gynecology.

Sample

One hundred pregnant women admitted for medical termination of pregnancy were enrolled; no pregnancies were over 55 days gestational age.

Methods

All subjects were randomly assigned for misoprostol administration either 2 or 48 h after mifepristone. All participants underwent transvaginal ultrasound examination for uterine contents 48 h and 3 weeks after mifepristone.

Main outcome measure

Procedure failure, defined as the presence of fetal heart activity, presence of a gestational sac, or a need for uterine curettage after misoprostol administration.

Results

Each group consisted of 50 women. Fetal heart activity was significantly more frequent after 48 h in the 2-h interval group (10/50) than in the 48-h interval group (0/50) (p = 0.002). Three weeks after misoprostol administration, fetal heart activity was present in 4/50 (8 %) in the 2-h interval group (p = 0.118) and none of the 48-h interval group. At 48 h residual tissue was present in 13/50 (26 %) and 5/50 (10 %) in the 2 and 48-h interval groups, respectively (p = 0.031); this was reduced to 12/50 (24 %) compared to 5/50 (10 %) in the two groups, respectively (p = 0.054) after 3 weeks.

Conclusions

Successful medical termination of pregnancy can be achieved using misoprostol administration 2 h after mifepristone in 76 % of cases. However, this regimen is not recommended as it is significantly inferior to the traditional 48-h interval regimen.
Literature
1.
go back to reference Sedgh G, Singh S, Shah IH, Ahman E, Henshaw SK, Bankole A (2012) Induced abortion: incidence and trends worldwide from 1995 to 2008. Lancet 379:625–632CrossRefPubMed Sedgh G, Singh S, Shah IH, Ahman E, Henshaw SK, Bankole A (2012) Induced abortion: incidence and trends worldwide from 1995 to 2008. Lancet 379:625–632CrossRefPubMed
2.
go back to reference Ulman A, Silvestre L, Chenama L et al (1992) Medical termination of early pregnancy with mifepristone (RU486) followed by prostaglandin analogue. Acta Obstet Gynecol Scand 71:278–283CrossRef Ulman A, Silvestre L, Chenama L et al (1992) Medical termination of early pregnancy with mifepristone (RU486) followed by prostaglandin analogue. Acta Obstet Gynecol Scand 71:278–283CrossRef
3.
go back to reference Fiala C, Gemzell-Danielsson K (2006) Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 74:66–86CrossRefPubMed Fiala C, Gemzell-Danielsson K (2006) Review of medical abortion using mifepristone in combination with a prostaglandin analogue. Contraception 74:66–86CrossRefPubMed
4.
go back to reference Sitruk-Ware R (1999) Medical recommendations for the safe use of mifepristone. In: Coutinho EM, Spinola P (eds) Reproductive medicine—a millennium review. The Parthenon Publishing Group, New York, pp 288–299 Sitruk-Ware R (1999) Medical recommendations for the safe use of mifepristone. In: Coutinho EM, Spinola P (eds) Reproductive medicine—a millennium review. The Parthenon Publishing Group, New York, pp 288–299
5.
go back to reference Schaff E, Fielding SL, Westhoff C et al (2000) Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. A randomized trial. JAMA 18(284):1948–1953CrossRef Schaff E, Fielding SL, Westhoff C et al (2000) Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. A randomized trial. JAMA 18(284):1948–1953CrossRef
6.
go back to reference Spitz IM, Bardin CW, Benton L, Robbins A (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Eng J Med 338:1241–1247CrossRef Spitz IM, Bardin CW, Benton L, Robbins A (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Eng J Med 338:1241–1247CrossRef
7.
go back to reference Peyron R, Aubeny E, Targosz V et al (1993) Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Eng J Med 328:1509–1513CrossRef Peyron R, Aubeny E, Targosz V et al (1993) Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Eng J Med 328:1509–1513CrossRef
8.
go back to reference Creinen MD, Schreiber CA, Bednarek P et al (2007) Mifepristone and mesoprostol administered simultaneously versus 24 hours apart for abortion. Obstet Gynecol 109:885–894CrossRef Creinen MD, Schreiber CA, Bednarek P et al (2007) Mifepristone and mesoprostol administered simultaneously versus 24 hours apart for abortion. Obstet Gynecol 109:885–894CrossRef
9.
go back to reference Creinen MD, Fox MC, Teal S et al (2004) A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 103:851–859CrossRef Creinen MD, Fox MC, Teal S et al (2004) A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 103:851–859CrossRef
10.
go back to reference Lahteenmaki P, Heikinheimo O, Croxatto H et al (1987) Pharmakokinetics and metabolism of RU 486. J Steroid Biochem 27:859–863CrossRefPubMed Lahteenmaki P, Heikinheimo O, Croxatto H et al (1987) Pharmakokinetics and metabolism of RU 486. J Steroid Biochem 27:859–863CrossRefPubMed
11.
go back to reference Heikinheimo O, Ylikorkala O, Turpeinen U, Lahteenmaki P (1990) Pharmacokinetics of the antiprogesterone RU 486: no correlation to clinical performance of RU486. Acta Endocrinol (Copenh) 123:298–304 Heikinheimo O, Ylikorkala O, Turpeinen U, Lahteenmaki P (1990) Pharmacokinetics of the antiprogesterone RU 486: no correlation to clinical performance of RU486. Acta Endocrinol (Copenh) 123:298–304
12.
go back to reference Ashok PW, Templton A, Wagaarachchi PT, Flet GMM (2002) Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynecol 109:1281–1289CrossRef Ashok PW, Templton A, Wagaarachchi PT, Flet GMM (2002) Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynecol 109:1281–1289CrossRef
13.
go back to reference Rorbye C, Norgaard M, Nilas L (2004) Prediction of late failure after medical abortion from serial β-HCG measurements and ultrasonography. Hum Reprod 19:85–89CrossRefPubMed Rorbye C, Norgaard M, Nilas L (2004) Prediction of late failure after medical abortion from serial β-HCG measurements and ultrasonography. Hum Reprod 19:85–89CrossRefPubMed
14.
go back to reference Odeh M, Tendler R, Sosnovsky V, Kais M, Ophir E, Bronstein J (2010) The effect of parity and gravidity on the outcome of medical termination of pregnancy. IMAJ 12:606–608PubMed Odeh M, Tendler R, Sosnovsky V, Kais M, Ophir E, Bronstein J (2010) The effect of parity and gravidity on the outcome of medical termination of pregnancy. IMAJ 12:606–608PubMed
15.
go back to reference Lohr PA, Reeves MF, Hayes JL, Harwood B, Creinen MD (2007) Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study. Contraception 76:215–220CrossRefPubMed Lohr PA, Reeves MF, Hayes JL, Harwood B, Creinen MD (2007) Oral mifepristone and buccal misoprostol administered simultaneously for abortion: a pilot study. Contraception 76:215–220CrossRefPubMed
16.
go back to reference Swahn ML, Bygdeman M (1988) The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. BJOG 95:126–134CrossRef Swahn ML, Bygdeman M (1988) The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. BJOG 95:126–134CrossRef
17.
go back to reference El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A (1995) Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med 332:983–987CrossRefPubMed El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A (1995) Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med 332:983–987CrossRefPubMed
Metadata
Title
Early versus late misoprostol administration after mifepristone for medical abortion
Authors
Rene Tendler
Jacob Bornstein
Mohamad Kais
Irina Masri
Marwan Odeh
Publication date
01-11-2015
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 5/2015
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-015-3722-1

Other articles of this Issue 5/2015

Archives of Gynecology and Obstetrics 5/2015 Go to the issue